AOPEP and metabolic syndrome: In conclusion, we observed that a high proportion of plasma palmitic acid was associated with greater insulin resistance in E4 carriers with MetS, whereas increasing plasma LC n-3 PUFA beneficially increased apo CII and reduced apo CIII concentrations in E2 carriers, which may confer TAG lowering benefits.